The live attenuated vaccine (LAV) SIVmac239Δnef (SIVΔnef) confers the best protection among all the vaccine modalities tested in rhesus macaque model of HIV-1 infection. This vaccine has a unique feature of time-dependent protection: macaques are not protected at 3±5 weeks post vaccination (WPV), whereas immune protection emerges between 15 and 20 WPV. Although the exact mechanisms of the time-dependent protection remain incompletely understood, studies suggested that both cellular and humoral immunities contribute to this time-dependent protection. To further elucidate the mechanisms of protection induced by SIVΔnef, we longitudinally compared the global gene expression profiles of SIV Gag-CM9+ CD8+ (Gag-specific CD8+) T cells from periphe...
The goal of an effective AIDS vaccine is to generate immunity that will prevent human immunodeficien...
AbstractAttempts to evaluate the protective effect of live attenuated SIV vaccine strains have yield...
SummaryEfforts to develop a vaccine against HIV have so far met with limited success. Given that CD4...
The live attenuated vaccine (LAV) SIVmac239Δnef (SIVΔnef) confers the best protection among all the ...
<div><p>The live attenuated vaccine (LAV) SIVmac239Δnef (SIVΔnef) confers the best protection among ...
The live attenuated vaccine (LAV) SIVmac239Δnef (SIVΔnef) confers the best protection among all the ...
Defining the correlates of immune protection conferred by SIVΔnef, the most effective vaccine agains...
AbstractThe ability of memory T cells to mount a recall response plays a key role in the ability of ...
Using whole-blood transcriptional profiling, we investigated differences in the host response to vac...
The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated macaques is ...
Additional contributors: Arun Sasikala-Appukuttan; Ashley Haase; Paul Johnson; Hyeon Kim; Jung Joo H...
<div><p>The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated maca...
Vaccination of Mauritian cynomolgus macaques with the attenuated nef-truncated C8 variant of SIVmac2...
Approximately 50% of rhesus macaques (RMs) expressing the major histocompatibility complex class I (...
While HIV-1-specific cellular immunity is thought to be critical for the suppression of viral replic...
The goal of an effective AIDS vaccine is to generate immunity that will prevent human immunodeficien...
AbstractAttempts to evaluate the protective effect of live attenuated SIV vaccine strains have yield...
SummaryEfforts to develop a vaccine against HIV have so far met with limited success. Given that CD4...
The live attenuated vaccine (LAV) SIVmac239Δnef (SIVΔnef) confers the best protection among all the ...
<div><p>The live attenuated vaccine (LAV) SIVmac239Δnef (SIVΔnef) confers the best protection among ...
The live attenuated vaccine (LAV) SIVmac239Δnef (SIVΔnef) confers the best protection among all the ...
Defining the correlates of immune protection conferred by SIVΔnef, the most effective vaccine agains...
AbstractThe ability of memory T cells to mount a recall response plays a key role in the ability of ...
Using whole-blood transcriptional profiling, we investigated differences in the host response to vac...
The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated macaques is ...
Additional contributors: Arun Sasikala-Appukuttan; Ashley Haase; Paul Johnson; Hyeon Kim; Jung Joo H...
<div><p>The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated maca...
Vaccination of Mauritian cynomolgus macaques with the attenuated nef-truncated C8 variant of SIVmac2...
Approximately 50% of rhesus macaques (RMs) expressing the major histocompatibility complex class I (...
While HIV-1-specific cellular immunity is thought to be critical for the suppression of viral replic...
The goal of an effective AIDS vaccine is to generate immunity that will prevent human immunodeficien...
AbstractAttempts to evaluate the protective effect of live attenuated SIV vaccine strains have yield...
SummaryEfforts to develop a vaccine against HIV have so far met with limited success. Given that CD4...